Checkpoint-inhibitor nun auch zur therapie des metastasierten merkelzellkarzinoms zugelassen

Translated title of the contribution: Checkpoint inhibitor now also approved for the treatment of metastatic Merkel cell carcinoma

Stephan Grabbe*, Patrick Terheyden, Jürgen C. Becker

*Corresponding author for this work
1 Citation (Scopus)
Translated title of the contributionCheckpoint inhibitor now also approved for the treatment of metastatic Merkel cell carcinoma
Original languageGerman
JournalJDDG - Journal of the German Society of Dermatology
Volume16
Issue number3
Pages (from-to)394-395
Number of pages2
ISSN1610-0379
DOIs
Publication statusPublished - 03.2018

Cite this